Stock Earnings Maxim Group analysts initates a Buy rating for Nuvectis Pharma Inc (NVCT) Nuvectis Pharma Inc’s recent filing unveils that its 10% Owner Mosseri Marlio Charles acquired Company’s shares for reported $44768.0 on